Atlas Trials

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Clinical trial NCT06238024 · COMPLETED

Trial details

NCT number
NCT06238024
Sponsor
Suzhou Municipal Hospital of Anhui Province
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Interleukin-6Ischemic StrokeEndovascular Treatment
Start date
2024-02-02
Primary completion
2024-06-25
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.